UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

12 Invited lecture: High-throughput functional genomics – An emerging field in head and neck cancer research

Oral oncology, 2015-05, Vol.51 (5), p.e31-e31

Brakenhoff, R.H

2015

Volltextzugriff (PDF)

Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing

Annals of oncology, 2018-05, Vol.29 (5), p.1273-1279

2018

Volltextzugriff (PDF)

SP-014: How to Detect and Use HPV Status?

Radiotherapy and oncology, 2013-02, Vol.106, p.S4-S5

Brakenhoff, R.H

2013

Volltextzugriff (PDF)

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x173-x177

2012

Volltextzugriff (PDF)

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data

European journal of cancer (1990), 2016-03, Vol.55, p.147-157

2016

Volltextzugriff (PDF)

Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma

American journal of neuroradiology : AJNR, 2015-04, Vol.36 (4), p.763-767

2015

Volltextzugriff (PDF)

41 Is HPV infection the first genetic hit in head and neck cancer?

Oral oncology, 2015-05, Vol.51 (5), p.e39-e40

2015

Volltextzugriff (PDF)

13 No molecular evidence for the role of the genetic background of the host in explaining lymph node metastasis in head and neck cancer

Oral oncology, 2015-05, Vol.51 (5), p.e31-e31

2015

Volltextzugriff (PDF)

33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors

Oral oncology, 2015-05, Vol.51 (5), p.e37-e37

2015

Volltextzugriff (PDF)

OC-0373: An HPV-based predictive model for oropharynx cancer yields more accurate predictions than TNM staging system

Radiotherapy and oncology, 2014, Vol.111, p.S144-S144

2014

Volltextzugriff (PDF)

6 CD98 identifies a clinically relevant subpopulation of head and neck squamous cell carcinoma cells with stem cell properties

Oral oncology, 2015-05, Vol.51 (5), p.e29-e29

2015

Volltextzugriff (PDF)

Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis

Clinical cancer research, 2009-02, Vol.15 (3), p.980-985

2009

Volltextzugriff (PDF)

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials

Annals of oncology, 2013-11, Vol.24 (11), p.2740-2745

2013

Volltextzugriff (PDF)

Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines

European journal of cancer (1990), 2003-06, Vol.39 (9), p.1310-1317

2003

Volltextzugriff (PDF)

Intratumor genetic heterogeneity and head and neck cancer relapse

Radiotherapy and oncology, 2024-02, Vol.191, p.110087, Article 110087

2024

Volltextzugriff (PDF)

Epidemiologic associations of HPV‐positive oropharyngeal cancer and (pre)cancerous cervical lesions

International journal of cancer, 2018-07, Vol.143 (2), p.283-288

2018

Volltextzugriff (PDF)

P-186 Neoadjuvant immune checkpoint inhibition in stage III/IV oral cancer patients: the NeoNivo trial

Oral oncology, 2021-07, Vol.118, p.4-4

2021

Volltextzugriff (PDF)

Genomic Adjusted Radiation Dose (GARD) Predicts Overall Survival and Outperforms AJCC 8th Edition in Prognostication of HPV-Positive Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S143

2022

Volltextzugriff (PDF)

214P Location matters: Oral cancer cells at the tumor invasive border that express GARP exclude immune cells

Immuno-oncology technology, 2022-12, Vol.16, p.100325, Article 100325

2022

Volltextzugriff (PDF)

911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study

Annals of oncology, 2020-09, Vol.31, p.S658-S659

2020

Volltextzugriff (PDF)

Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC)

Annals of oncology, 2018-10, Vol.29, p.viii376-viii376

2018

Volltextzugriff (PDF)

PV-0312 Distributed learning in radiomics to predict overall survival in head and neck cancer

Radiotherapy and oncology, 2019-04, Vol.133, p.S160-S161

2019

Volltextzugriff (PDF)

50 INVITED Human papillomavirus infection in head and neck squamous cell carcinoma: another route to cancer

European journal of cancer supplements, 2007, Vol.5 (4), p.17-17

2007

Volltextzugriff (PDF)

Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions

Gene therapy, 2010-12, Vol.17 (12), p.1517-1524

2010

Volltextzugriff (PDF)

Head and neck cancer: molecular carcinogenesis

Annals of oncology, 2005-06, Vol.16 (suppl-2), p.ii249-ii250

2005

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

12 Invited lecture: High-throughput functional genomics – An emerging field in head and neck cancer research

Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing

SP-014: How to Detect and Use HPV Status?

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data

Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma

41 Is HPV infection the first genetic hit in head and neck cancer?

13 No molecular evidence for the role of the genetic background of the host in explaining lymph node metastasis in head and neck cancer

33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors

OC-0373: An HPV-based predictive model for oropharynx cancer yields more accurate predictions than TNM staging system

6 CD98 identifies a clinically relevant subpopulation of head and neck squamous cell carcinoma cells with stem cell properties

Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials

Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines

Intratumor genetic heterogeneity and head and neck cancer relapse

Epidemiologic associations of HPV‐positive oropharyngeal cancer and (pre)cancerous cervical lesions

P-186 Neoadjuvant immune checkpoint inhibition in stage III/IV oral cancer patients: the NeoNivo trial

Genomic Adjusted Radiation Dose (GARD) Predicts Overall Survival and Outperforms AJCC 8th Edition in Prognostication of HPV-Positive Oropharyngeal Squamous Cell Carcinoma

214P Location matters: Oral cancer cells at the tumor invasive border that express GARP exclude immune cells

911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study

Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC)

PV-0312 Distributed learning in radiomics to predict overall survival in head and neck cancer

50 INVITED Human papillomavirus infection in head and neck squamous cell carcinoma: another route to cancer

Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions

Head and neck cancer: molecular carcinogenesis

Suchergebnisse filtern